Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$956M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$924M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$769M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$410M |
| 5 |
Kenvue
KVUE
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$411M |
| 2 |
Johnson & Johnson
JNJ
|
+$234M |
| 3 |
Cisco
CSCO
|
+$181M |
| 4 |
iShares Gold Trust
IAU
|
+$143M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.03% |
| 2 | Healthcare | 12.31% |
| 3 | Financials | 11.79% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Live Oak Bancshares
LOB
$2.02B
| $7.42M | ﹤0.01% |
256,252
+6,066
| +2% | +$195K |
|
2077
Janus International
JBI
$771M
| $7.42M | ﹤0.01% |
693,113
+87,996
| +15% | +$969K |
|
2078
Syndax Pharmaceuticals
SNDX
$1.69B
| $7.35M | ﹤0.01% |
506,467
+15,156
| +3% | +$287K |
|
|
AVID
2079
DELISTED
Avid Technology Inc
AVID
| $7.33M | ﹤0.01% |
272,903
-46,386
| -15% | -$1.22M |
|
2080
Protagonist Therapeutics
PTGX
$8.73B
| $7.32M | ﹤0.01% |
439,102
+19,492
| +5% | +$378K |
|
2081
CRA International
CRAI
$1.17B
| $7.32M | ﹤0.01% |
72,607
+41,486
| +133% | +$4.36M |
|
2082
Levi Strauss
LEVI
$9.43B
| $7.31M | ﹤0.01% |
538,163
+26,902
| +5% | +$376K |
|
2083
Unisys
UIS
$218M
| $7.28M | ﹤0.01% |
2,111,590
+480,534
| +29% | +$2.03M |
|
2084
Pliant Therapeutics
PLRX
$65M
| $7.25M | ﹤0.01% |
418,206
+61,376
| +17% | +$1.06M |
|
2085
Quanterix
QTRX
$175M
| $7.25M | ﹤0.01% |
267,027
+5,981
| +2% | +$148K |
|
2086
Magnite
MGNI
$2.99B
| $7.24M | ﹤0.01% |
959,600
+34,930
| +4% | +$377K |
|
2087
ARKO Corp
ARKO
$840M
| $7.22M | ﹤0.01% |
1,010,381
+42,177
| +4% | +$330K |
|
2088
Utz Brands
UTZ
$1.25B
| $7.17M | ﹤0.01% |
533,635
+23,109
| +5% | +$356K |
|
2089
N-able
NABL
$981M
| $7.17M | ﹤0.01% |
555,504
+36,624
| +7% | +$499K |
|
|
BBT
2090
Beacon Financial Corp
BBT
$2.71B
| $7.12M | ﹤0.01% |
355,266
+9,532
| +3% | +$204K |
|
2091
Sinclair Inc
SBGI
$1.01B
| $7.12M | ﹤0.01% |
634,607
+34,595
| +6% | +$446K |
|
|
THR
2092
DELISTED
Thermon Group Holdings
THR
| $7.12M | ﹤0.01% |
259,172
+7,178
| +3% | +$193K |
|
2093
Globalstar
GSAT
$10.8B
| $7.12M | ﹤0.01% |
362,199
+10,514
| +3% | +$189K |
|
2094
Mirum Pharmaceuticals
MIRM
$6.36B
| $7.1M | ﹤0.01% |
224,571
+152,287
| +211% | +$4.17M |
|
|
INFA
2095
DELISTED
Informatica
INFA
| $7.09M | ﹤0.01% |
336,645
+14,729
| +5% | +$294K |
|
2096
Children's Place
PLCE
$59.2M
| $7.09M | ﹤0.01% |
262,360
+11,198
| +4% | +$304K |
|
2097
WisdomTree
WT
$3.42B
| $7.09M | ﹤0.01% |
1,013,058
+48,187
| +5% | +$337K |
|
2098
Center Bancorp
CNOB
$1.69B
| $7.08M | ﹤0.01% |
397,188
+55,682
| +16% | +$1.04M |
|
2099
Titan International
TWI
$483M
| $7.05M | ﹤0.01% |
525,219
+21,885
| +4% | +$267K |
|
2100
Compass
COMP
$8.97B
| $7.01M | ﹤0.01% |
2,418,319
+339,055
| +16% | +$1.2M |
|
Similar funds
Charles Schwab's Q3 2023 Portfolio in Review
As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.
- Charles Schwab's largest Q3 2023 buy was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
- Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
- Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
- Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
- Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
- Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
- Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.
Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.